Tech Center 3700 • Art Units: 3795
This examiner grants 66% of resolved cases
Li-Ting Song operates in Art Unit 3795 within Tech Center 3700. She has 93 resolved cases with an allowance rate of 65.6%. The median days to allowance is 1105, providing a benchmark for the prosecution timeline.
The interview lift of 32.9% is significant. This suggests that an interview can be a very effective tool for increasing the 65.6% baseline allowance rate. Practitioners should consider an interview as a way to address examiner concerns and move toward an allowance within the 1105-day median period. The 93 resolved cases indicate a stable pattern of examination. While the 65.6% allowance rate is moderate, the 32.9% lift provides a clear path for improving the odds of success. Engaging in direct communication can help clarify technical points and potentially streamline the overall process for applications assigned to this examiner in Art Unit 3795.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18986298 | DEGRADABLE SUCTION VALVE FOR AN ENDOSCOPE | Non-Final OA | Boston Scientific Scimed, Inc. |
| 18939041 | ARTICULATING MEDICAL DEVICES AND ASSOCIATED METHODS | Non-Final OA | Boston Scientific Scimed, Inc. |
| 18493330 | INSERTION DEVICE WITH DISTAL CHAMBER | Final Rejection | Boston Scientific Scimed, Inc. |
| 19040863 | MEDICAL SUPPORT DEVICE, ENDOSCOPE, MEDICAL SUPPORT METHOD, AND PROGRAM | Non-Final OA | FUJIFILM CORPORATION |
| 19034572 | ENDOSCOPE SYSTEM | Non-Final OA | FUJIFILM Corporation |
| 18825907 | EXPANSION UNIT OF ENDOSCOPE AND ADAPTER DEVICE OF ENDOSCOPE | Non-Final OA | FUJIFILM Corporation |
| 19223089 | MEDICAL SYSTEM, MEDICAL LIGHT SOURCE APPARATUS, AND METHOD IN MEDICAL LIGHT SOURCE APPARATUS | Non-Final OA | Sony Group Corporation |
| 18762807 | BILE DUCT/PANCREATIC DUCT TREATMENT METHOD AND ENDOSCOPIC INSTRUMENT | Final Rejection | OLYMPUS CORPORATION |
| 18778418 | Dual View Endoscope | Final Rejection | OmniVision Technologies, Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy